XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Common Stock
Capital Surplus [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Deferred Benefits for Directors [Member]
Beginning Balance at Dec. 31, 2019 $ 2,593,921 $ (26,591)   $ 141,827 $ 1,636,966 $ 824,694 $ (26,591) $ (9,463) $ 1,201 $ (1,304)
Beginning Balance, shares at Dec. 31, 2019       67,824,428            
Net income 23,396         23,396        
Other comprehensive income (loss) 39,940               39,940  
Comprehensive income 63,336                  
Common dividends declared $ (21,435)         (21,435)        
Accounting Standards Update [Extensible List] ASU 2016-13 [Member]                  
Treasury shares acquired $ (24,972)             (24,972)    
Treasury shares acquired, shares       (786,012)            
Stock options exercised 445       (276)     721    
Stock options exercised, shares       19,739            
Stock compensation expense 1,370       1,370          
Deferred benefits for directors- net (14)       62         (76)
Ending Balance at Mar. 31, 2020 2,586,060     $ 141,827 1,638,122 800,064   (33,714) 41,141 (1,380)
Ending Balance, shares at Mar. 31, 2020       67,058,155            
Beginning Balance at Dec. 31, 2020 2,756,737   $ 144,484 $ 141,834 1,634,815 831,688   (25,949) 31,359 (1,494)
Beginning Balance, shares at Dec. 31, 2020       67,254,706            
Net income 73,115         73,115        
Other comprehensive income (loss) (21,556)               (21,556)  
Comprehensive income 51,559                  
Common dividends declared (22,095)         (22,095)        
Preferred dividends declared ($16.875 per share) (2,531)         (2,531)        
Stock issued for dividend reinvestment           (391)   391    
Stock issued for dividend reinvestment, shares       11,720            
Treasury shares acquired         183     (183)    
Treasury shares acquired, shares       (5,135)            
Stock options exercised 569       (183)     752    
Stock options exercised, shares       20,843            
Stock compensation expense 1,288       1,288          
Deferred benefits for directors- net (5)                 (5)
Ending Balance at Mar. 31, 2021 $ 2,785,522   $ 144,484 $ 141,834 $ 1,636,103 $ 879,786   $ (24,989) $ 9,803 $ (1,499)
Ending Balance, shares at Mar. 31, 2021       67,282,134